The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
出版年份 2021 全文链接
标题
The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
作者
关键词
-
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-12
DOI
10.1007/s00280-021-04337-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer
- (2021) Soheila Delgir et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance
- (2021) Ewa Gajda et al. Pharmaceuticals
- Polymeric Nanocarriers: A Transformation in Doxorubicin Therapies
- (2021) Kamila Butowska et al. Materials
- MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway
- (2020) Guohua Lou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer
- (2020) Ye Wang et al. OncoTargets and Therapy
- MicroRNA‐221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling
- (2020) Yingchun Yin et al. Cancer Medicine
- The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway
- (2020) Zhaolin Chen et al. Molecular Therapy-Nucleic Acids
- Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
- (2020) József Dudás et al. Cells
- LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22
- (2020) Kewei Zhu et al. Aging-US
- MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc
- (2020) Li Tao et al. BIOMEDICINE & PHARMACOTHERAPY
- Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
- (2020) Qingjian Li et al. Nature Communications
- Jack of all trades? The versatility of RNA in DNA double-strand break repair
- (2020) Ruth F. Ketley et al. Essays in Biochemistry
- Combinatory Treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs Cancer Cells
- (2020) Ewa Gajda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical and In Silico Outcomes of miR-130a-5p and miR-615-3p Expression in Tumor Compared with Non-Tumor Adjacent Tissues of Patients with BC
- (2020) Khandan Ilkhani et al. Anti-Cancer Agents in Medicinal Chemistry
- miRNAs Modulate the Dichotomy of Cisplatin Resistance or Sensitivity in Breast Cancer: An Update of Therapeutic Implications
- (2020) Asma Safi et al. Anti-Cancer Agents in Medicinal Chemistry
- The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators
- (2020) Khandan Ilkhani et al. Anti-Cancer Agents in Medicinal Chemistry
- The role of epigenetics and non-coding RNAs in autophagy: A new perspective for thorough understanding
- (2020) Shahrzad Talebian et al. MECHANISMS OF AGEING AND DEVELOPMENT
- MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma
- (2020) Xiao Cui et al. Translational Oncology
- The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity
- (2020) Rodolfo Chavez-Dominguez et al. Frontiers in Oncology
- Concomitant overexpression of mir‐182‐5p and mir‐182‐3p raises the possibility of IL‐17–producing Treg formation in breast cancer by targeting CD3d, ITK, FOXO1, and NFATs: A meta‐analysis and experimental study
- (2020) Mohammad Hasan Soheilifar et al. CANCER SCIENCE
- ZEB1 mediates doxorubicin (Dox) resistance and mesenchymal characteristics of hepatocarcinoma cells
- (2019) Lin Long et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Foxo3a-dependent miR-633 regulates chemotherapeutic sensitivity in gastric cancer by targeting Fas-associated death domain
- (2019) Xin Pang et al. RNA Biology
- MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
- (2019) Lanlan Gao et al. EBioMedicine
- Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein
- (2019) Huaiming Wang et al. MEDICAL SCIENCE MONITOR
- microRNA‐431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma
- (2019) Grace T.Y. Kwok et al. ONCOLOGIST
- MicroRNA‐26a inhibits multiple myeloma cell growth by suppressing cyclin‐dependent kinase 6 expression
- (2019) Ying‐Ying Xu et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A
- (2019) Yi Zhang et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2
- (2019) Chaoyong Tu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MiR-202-5p/PTEN mediates doxorubicin-resistance of breast cancer cells via PI3K/Akt signaling pathway
- (2019) Tao Liu et al. CANCER BIOLOGY & THERAPY
- Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy
- (2019) Lisa Pfitzer et al. Cell Death & Disease
- MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway
- (2019) Hong Dai et al. BIOSCIENCE REPORTS
- MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer
- (2019) Jinzhi Lai et al. BMC CANCER
- Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
- (2019) Claudia Christowitz et al. BMC CANCER
- Poly(ADP-ribose) polymerase-1 antagonizes DNA resection at double-strand breaks
- (2019) Marie-Christine Caron et al. Nature Communications
- Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
- (2019) Shu Lin et al. Cell Death & Disease
- Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy
- (2019) Chunai Gong et al. JOURNAL OF NANOBIOTECHNOLOGY
- MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4
- (2019) Yi-Fei Wang et al. Frontiers in Genetics
- Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
- (2019) Khan et al. Cells
- Enhanced anticancer efficiency of doxorubicin against human glioma by natural borneol through triggering ROS-mediated signal
- (2019) Wen-qiang Cao et al. BIOMEDICINE & PHARMACOTHERAPY
- Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
- (2019) Zahra Bolandghamat Pour et al. BMC CANCER
- miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells
- (2019) Yue Zhou et al. Cell Death & Disease
- MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1
- (2019) Lu Liang et al. Acta Pharmaceutica Sinica B
- miR-149 inhibits cell proliferation and enhances chemosensitivity by targeting CDC42 and BCL2 in neuroblastoma
- (2019) Fengxia Mao et al. Cancer Cell International
- miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
- (2019) Feiya Du et al. Cell Death & Disease
- MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies
- (2019) Hyun Ah Seo et al. Cells
- MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer
- (2018) Jin-Won Lee et al. CANCER SCIENCE
- SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer
- (2018) Xu Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer
- (2018) Mithil Soni et al. MOLECULAR CANCER RESEARCH
- Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
- (2018) Stefania Gorini et al. Oxidative Medicine and Cellular Longevity
- Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies
- (2018) Pierpaola Davalli et al. Oxidative Medicine and Cellular Longevity
- MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
- (2018) Yaming Li et al. Cell Death & Disease
- Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells
- (2018) Martin C. Pearce et al. Oncotarget
- Novel mechanism of doxorubicin resistance and tumorigenesis mediated by microRNA-501-5p suppressed BLID
- (2018) Yun-chao Xu et al. Molecular Therapy-Nucleic Acids
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Asteriscus graveolens Extract in Combination with Cisplatin/Etoposide/Doxorubicin Suppresses Lymphoma Cell Growth through Induction of Caspase-3 Dependent Apoptosis
- (2018) Zainab Tayeh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Autophagy-dependent cell death
- (2018) Donna Denton et al. CELL DEATH AND DIFFERENTIATION
- Non-coding RNA NEAT1/miR-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the Wnt/β-catenin pathway
- (2018) Yan Guo et al. Cancer Management and Research
- Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin
- (2018) Wei Chen et al. BIOMATERIALS
- Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma
- (2017) Huiying Xue et al. International Journal of Nanomedicine
- miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
- (2017) Zhenyou Zou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer
- (2017) Mehdi Ariana et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications
- (2017) Maryam Zare et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma
- (2017) Ren Chen et al. Molecular Medicine Reports
- Census and evaluation of p53 target genes
- (2017) M Fischer ONCOGENE
- miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
- (2017) Shihua Chu et al. ONCOLOGY REPORTS
- The role of p53-microRNA 200-Moesin axis in invasion and drug resistance of breast cancer cells
- (2017) Farheen Alam et al. TUMOR BIOLOGY
- MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy
- (2017) Fangfang Jin et al. Cell Death & Disease
- MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS
- (2017) Yi Xiao et al. Oncology Letters
- MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway
- (2017) Yan Shu et al. Oncotarget
- Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
- (2017) Jinglu Wang et al. Oncotarget
- MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2
- (2017) Qiang Xiao et al. Oncotarget
- MicroRNA-7641 is a regulator of ribosomal proteins and a promising targeting factor to improve the efficacy of cancer therapy
- (2017) Abu Musa Md. Talimur Reza et al. Scientific Reports
- MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma
- (2017) Fei Xu et al. Cancer Medicine
- MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma
- (2017) Yin-Ping Fan et al. Molecular Therapy-Nucleic Acids
- Regulation of multidrug resistance by microRNAs in anti-cancer therapy
- (2017) Xin An et al. Acta Pharmaceutica Sinica B
- MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy
- (2017) Yichen Meng et al. Scientific Reports
- MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway
- (2017) Yuan Miao et al. Scientific Reports
- Erratum: miR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin
- (2017) Nibedita Patel et al. Scientific Reports
- miR-140-5p attenuates chemotherapeutic drug-induced cell death by regulating autophagy through inositol 1,4,5-trisphosphate kinase 2 (IP3k2) in human osteosarcoma cells
- (2016) R. Wei et al. BIOSCIENCE REPORTS
- Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells
- (2016) Mengjie Rui et al. International Journal of Nanomedicine
- MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
- (2016) Lin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-Delivery Triggered by Dual Stimuli in Tumor Tissue
- (2016) Giuseppina Salzano et al. Small
- miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway
- (2016) Dan-dan Wang et al. TUMOR BIOLOGY
- The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration
- (2016) A E Hall et al. Cell Death & Disease
- miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
- (2016) Y Hu et al. Cell Death & Disease
- The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC
- (2016) Lei Li et al. Oncology Letters
- miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
- (2016) Man Gao et al. Oncotarget
- Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia
- (2016) Lifen Zhao et al. Oncotarget
- MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway
- (2016) Zhiyun Zheng et al. Oncotarget
- A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer
- (2016) Do Yeon Kim et al. Oncotarget
- Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs
- (2016) Eun-Ae Kim et al. Oncotarget
- The influence of a caveolin-1 mutant on the function of P-glycoprotein
- (2016) Chih-Yuan Lee et al. Scientific Reports
- Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas
- (2016) Shuhei Osaki et al. Scientific Reports
- MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1
- (2016) Bo-chuan Lin et al. MEDICAL SCIENCE MONITOR
- Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice
- (2016) Jayanth Suryanarayanan Shankaranarayanan et al. Scientific Reports
- MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma
- (2016) Yangbai Sun et al. Scientific Reports
- Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth
- (2015) Yong Zhao et al. BIOCHEMICAL PHARMACOLOGY
- MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1
- (2015) Lin Lu et al. BIOTECHNOLOGY LETTERS
- Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
- (2015) Khalid O Alfarouk et al. Cancer Cell International
- Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer
- (2015) B. Yoo et al. CANCER RESEARCH
- Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines
- (2015) Derek Edwardson et al. CURRENT DRUG METABOLISM
- MicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy Efficacy
- (2015) Maddalena Mognato et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- MicroRNA Therapeutics: the Next Magic Bullet?
- (2015) Bridget Simonson et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- miR-382 Inhibits Osteosarcoma Metastasis and Relapse by Targeting Y Box-Binding Protein 1
- (2015) Meng Xu et al. MOLECULAR THERAPY
- Anthracyclines induce double-strand DNA breaks at active gene promoters
- (2015) Fan Yang et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- miR-181b promotes chemoresistance in breast cancer by regulating Bim expression
- (2015) YABING ZHENG et al. ONCOLOGY REPORTS
- MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy
- (2015) RUIDA XU et al. ONCOLOGY REPORTS
- miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1
- (2015) Zuoren Yu et al. Oncotarget
- Doubling Down on the PI3K-AKT-mTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness
- (2015) Pradip De et al. NEOPLASIA
- Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation
- (2014) Zhen Zhao et al. CANCER BIOLOGY & THERAPY
- Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
- (2014) E. Y. Park et al. CANCER RESEARCH
- ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
- (2014) Young Choi et al. CURRENT PHARMACEUTICAL DESIGN
- Regulation of BGC-823 cell sensitivity to adriamycin via miRNA-135a-5p
- (2014) YANMING PAN et al. ONCOLOGY REPORTS
- The miR-106b∼25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300
- (2013) Y Zhou et al. CELL DEATH AND DIFFERENTIATION
- Cdks, cyclins and CKIs: roles beyond cell cycle regulation
- (2013) S. Lim et al. DEVELOPMENT
- Downregulation of histone deacetylase 1 by microRNA-520h contributes to the chemotherapeutic effect of doxorubicin
- (2013) Qi Shen et al. FEBS LETTERS
- Molecular mechanisms of radiation resistance in doxorubicin-resistant breast adenocarcinoma cells
- (2013) LIDIA LUZHNA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer
- (2013) BERLINDA VERDOODT et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Progress in microRNA delivery
- (2013) Yu Zhang et al. JOURNAL OF CONTROLLED RELEASE
- miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
- (2013) YONG CHEN et al. Molecular Medicine Reports
- miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1
- (2013) Y Shang et al. ONCOGENE
- miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells
- (2013) A A Takwi et al. ONCOGENE
- Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance
- (2013) Yan Xu et al. PLoS One
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
- (2013) Jessica Bockhorn et al. Nature Communications
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
- (2012) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- MicroRNAs and DNA damage response
- (2012) Yemin Wang et al. CELL CYCLE
- miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
- (2012) Florian Kopp et al. PLoS One
- Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1
- (2012) Bray Denard et al. eLife
- Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21
- (2011) N. Tsuchiya et al. CANCER RESEARCH
- Extracellular Signal-Regulated Kinases Modulate DNA Damage Response - A Contributing Factor to Using MEK Inhibitors in Cancer Therapy
- (2011) F. Wei et al. CURRENT MEDICINAL CHEMISTRY
- Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
- (2011) Junqing Chen et al. MEDICAL ONCOLOGY
- Posttranscriptional regulation of miRNAs in the DNA damage response
- (2011) Xinna Zhang et al. RNA Biology
- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- Oncogenic Wip1 Phosphatase Is Inhibited by miR-16 in the DNA Damage Signaling Pathway
- (2010) X. Zhang et al. CANCER RESEARCH
- The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
- (2010) Stephen L. Abrams et al. CELL CYCLE
- Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors
- (2010) Neil Johnson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair
- (2010) Ismail Hassan Ismail et al. JOURNAL OF CELL BIOLOGY
- p53 activates the PANK1/ miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins
- (2010) Levin Böhlig et al. NUCLEIC ACIDS RESEARCH
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
- (2009) F. Fornari et al. CANCER RESEARCH
- Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells
- (2008) C.-Y. Han et al. CARCINOGENESIS
- MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
- (2008) I. Ivanovska et al. MOLECULAR AND CELLULAR BIOLOGY
- FOXOs, cancer and regulation of apoptosis
- (2008) Z Fu et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started